Global and Japan Avian Influenza Vaccines Market Insights, Forecast to 2027

Publisher Name :
Date: 02-Sep-2021
No. of pages: 161
Inquire Before Buying

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

Market Analysis and Insights: Global and Japan Avian Influenza Vaccines Market

This report focuses on global and Japan Avian Influenza Vaccines market.

In 2020, the global Avian Influenza Vaccines market size was US$ 914 million and it is expected to reach US$ 1307.8 million by the end of 2027, with a CAGR of 5.5% during 2021-2027. In Japan the Avian Influenza Vaccines market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Avian Influenza Vaccines Scope and Market Size

Avian Influenza Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Avian Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Avian Influenza Vaccines market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- H5+H7 Avian Influenza Vaccines

- H9 Avian Influenza Vaccines

Segment by Application

- Chicken Avian Influenza Vaccines

- Duck & Goose Avian Influenza Vaccines

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Merial

- QYH Biotech

- DHN

- HVRI

- CEVA

- Elanco (Lohmann )

- Yebio

- Zoetis

- FATRO

- Kyoto Biken

- CAVAC

- Ringpu Biology

- Vaksindo

- ChengDu Tecbond

- Sindh Poultry Vaccine Centre

- Merck Animal Health

- Medion

- Avimex Animal Health

- JOVAC

- Bio-Labs

Global and Japan Avian Influenza Vaccines Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Avian Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Avian Influenza Vaccines Market Size Growth Rate by Type
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Market by Application
1.3.1 Global Avian Influenza Vaccines Market Size Growth Rate by Application
1.3.2 Chicken Avian Influenza Vaccines
1.3.3 Duck & Goose Avian Influenza Vaccines
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Avian Influenza Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Avian Influenza Vaccines Revenue 2016-2027
2.1.2 Global Avian Influenza Vaccines Sales 2016-2027
2.2 Global Avian Influenza Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Avian Influenza Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Avian Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Avian Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Avian Influenza Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Avian Influenza Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Avian Influenza Vaccines Revenue Forecast by Region (2022-2027)
3 Global Avian Influenza Vaccines Competitor Landscape by Players
3.1 Global Top Avian Influenza Vaccines Manufacturers by Sales
3.1.1 Global Avian Influenza Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Avian Influenza Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Avian Influenza Vaccines Manufacturers by Revenue
3.2.1 Key Avian Influenza Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Avian Influenza Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Avian Influenza Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Avian Influenza Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Avian Influenza Vaccines Revenue in 2020
3.2.6 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Avian Influenza Vaccines Price by Manufacturers
3.4 Global Avian Influenza Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Avian Influenza Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Avian Influenza Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Avian Influenza Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Avian Influenza Vaccines Market Size by Type (2016-2021)
4.1.1 Global Avian Influenza Vaccines Sales by Type (2016-2021)
4.1.2 Global Avian Influenza Vaccines Revenue by Type (2016-2021)
4.1.3 Avian Influenza Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Avian Influenza Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Avian Influenza Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Avian Influenza Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Avian Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Avian Influenza Vaccines Market Size by Application (2016-2021)
5.1.1 Global Avian Influenza Vaccines Sales by Application (2016-2021)
5.1.2 Global Avian Influenza Vaccines Revenue by Application (2016-2021)
5.1.3 Avian Influenza Vaccines Price by Application (2016-2021)
5.2 Avian Influenza Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Avian Influenza Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Avian Influenza Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Avian Influenza Vaccines Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Avian Influenza Vaccines Market Size YoY Growth 2016-2027
6.1.1 Japan Avian Influenza Vaccines Sales YoY Growth 2016-2027
6.1.2 Japan Avian Influenza Vaccines Revenue YoY Growth 2016-2027
6.1.3 Japan Avian Influenza Vaccines Market Share in Global Market 2016-2027
6.2 Japan Avian Influenza Vaccines Market Size by Players (International and Local Players)
6.2.1 Japan Top Avian Influenza Vaccines Players by Sales (2016-2021)
6.2.2 Japan Top Avian Influenza Vaccines Players by Revenue (2016-2021)
6.3 Japan Avian Influenza Vaccines Historic Market Review by Type (2016-2021)
6.3.1 Japan Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
6.3.2 Japan Avian Influenza Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 Japan Avian Influenza Vaccines Price by Type (2016-2021)
6.4 Japan Avian Influenza Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Avian Influenza Vaccines Sales Forecast by Type (2022-2027)
6.4.2 Japan Avian Influenza Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 Japan Avian Influenza Vaccines Price Forecast by Type (2022-2027)
6.5 Japan Avian Influenza Vaccines Historic Market Review by Application (2016-2021)
6.5.1 Japan Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
6.5.2 Japan Avian Influenza Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 Japan Avian Influenza Vaccines Price by Application (2016-2021)
6.6 Japan Avian Influenza Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Avian Influenza Vaccines Sales Forecast by Application (2022-2027)
6.6.2 Japan Avian Influenza Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 Japan Avian Influenza Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Avian Influenza Vaccines Market Size YoY Growth 2016-2027
7.2 North America Avian Influenza Vaccines Market Facts & Figures by Country
7.2.1 North America Avian Influenza Vaccines Sales by Country (2016-2021)
7.2.2 North America Avian Influenza Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Avian Influenza Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Avian Influenza Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Avian Influenza Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Avian Influenza Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Avian Influenza Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Avian Influenza Vaccines Market Facts & Figures by Country
9.2.1 Europe Avian Influenza Vaccines Sales by Country (2016-2021)
9.2.2 Europe Avian Influenza Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Avian Influenza Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Avian Influenza Vaccines Market Facts & Figures by Country
10.2.1 Latin America Avian Influenza Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Avian Influenza Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Avian Influenza Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Avian Influenza Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Merial
12.1.1 Merial Corporation Information
12.1.2 Merial Description and Business Overview
12.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merial Avian Influenza Vaccines Products Offered
12.1.5 Merial Recent Development
12.2 QYH Biotech
12.2.1 QYH Biotech Corporation Information
12.2.2 QYH Biotech Description and Business Overview
12.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 QYH Biotech Avian Influenza Vaccines Products Offered
12.2.5 QYH Biotech Recent Development
12.3 DHN
12.3.1 DHN Corporation Information
12.3.2 DHN Description and Business Overview
12.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 DHN Avian Influenza Vaccines Products Offered
12.3.5 DHN Recent Development
12.4 HVRI
12.4.1 HVRI Corporation Information
12.4.2 HVRI Description and Business Overview
12.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 HVRI Avian Influenza Vaccines Products Offered
12.4.5 HVRI Recent Development
12.5 CEVA
12.5.1 CEVA Corporation Information
12.5.2 CEVA Description and Business Overview
12.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CEVA Avian Influenza Vaccines Products Offered
12.5.5 CEVA Recent Development
12.6 Elanco (Lohmann )
12.6.1 Elanco (Lohmann ) Corporation Information
12.6.2 Elanco (Lohmann ) Description and Business Overview
12.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Products Offered
12.6.5 Elanco (Lohmann ) Recent Development
12.7 Yebio
12.7.1 Yebio Corporation Information
12.7.2 Yebio Description and Business Overview
12.7.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Yebio Avian Influenza Vaccines Products Offered
12.7.5 Yebio Recent Development
12.8 Zoetis
12.8.1 Zoetis Corporation Information
12.8.2 Zoetis Description and Business Overview
12.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Zoetis Avian Influenza Vaccines Products Offered
12.8.5 Zoetis Recent Development
12.9 FATRO
12.9.1 FATRO Corporation Information
12.9.2 FATRO Description and Business Overview
12.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 FATRO Avian Influenza Vaccines Products Offered
12.9.5 FATRO Recent Development
12.10 Kyoto Biken
12.10.1 Kyoto Biken Corporation Information
12.10.2 Kyoto Biken Description and Business Overview
12.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Kyoto Biken Avian Influenza Vaccines Products Offered
12.10.5 Kyoto Biken Recent Development
12.11 Merial
12.11.1 Merial Corporation Information
12.11.2 Merial Description and Business Overview
12.11.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merial Avian Influenza Vaccines Products Offered
12.11.5 Merial Recent Development
12.12 Ringpu Biology
12.12.1 Ringpu Biology Corporation Information
12.12.2 Ringpu Biology Description and Business Overview
12.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Ringpu Biology Products Offered
12.12.5 Ringpu Biology Recent Development
12.13 Vaksindo
12.13.1 Vaksindo Corporation Information
12.13.2 Vaksindo Description and Business Overview
12.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Vaksindo Products Offered
12.13.5 Vaksindo Recent Development
12.14 ChengDu Tecbond
12.14.1 ChengDu Tecbond Corporation Information
12.14.2 ChengDu Tecbond Description and Business Overview
12.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.14.4 ChengDu Tecbond Products Offered
12.14.5 ChengDu Tecbond Recent Development
12.15 Sindh Poultry Vaccine Centre
12.15.1 Sindh Poultry Vaccine Centre Corporation Information
12.15.2 Sindh Poultry Vaccine Centre Description and Business Overview
12.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sindh Poultry Vaccine Centre Products Offered
12.15.5 Sindh Poultry Vaccine Centre Recent Development
12.16 Merck Animal Health
12.16.1 Merck Animal Health Corporation Information
12.16.2 Merck Animal Health Description and Business Overview
12.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Merck Animal Health Products Offered
12.16.5 Merck Animal Health Recent Development
12.17 Medion
12.17.1 Medion Corporation Information
12.17.2 Medion Description and Business Overview
12.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Medion Products Offered
12.17.5 Medion Recent Development
12.18 Avimex Animal Health
12.18.1 Avimex Animal Health Corporation Information
12.18.2 Avimex Animal Health Description and Business Overview
12.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Avimex Animal Health Products Offered
12.18.5 Avimex Animal Health Recent Development
12.19 JOVAC
12.19.1 JOVAC Corporation Information
12.19.2 JOVAC Description and Business Overview
12.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.19.4 JOVAC Products Offered
12.19.5 JOVAC Recent Development
12.20 Bio-Labs
12.20.1 Bio-Labs Corporation Information
12.20.2 Bio-Labs Description and Business Overview
12.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Bio-Labs Products Offered
12.20.5 Bio-Labs Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Avian Influenza Vaccines Industry Trends
13.2 Avian Influenza Vaccines Market Drivers
13.3 Avian Influenza Vaccines Market Challenges
13.4 Avian Influenza Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Avian Influenza Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Avian Influenza Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of H5+H7 Avian Influenza Vaccines
Table 3. Major Manufacturers of H9 Avian Influenza Vaccines
Table 4. Global Avian Influenza Vaccines Market Size Growth Rate by Application (2021-2027) & (M Doses)
Table 5. Global Avian Influenza Vaccines Market Size by Region (M Doses) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Avian Influenza Vaccines Sales by Regions (2016-2021) & (M Doses)
Table 7. Global Avian Influenza Vaccines Sales Market Share by Regions (2016-2021)
Table 8. Global Avian Influenza Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Avian Influenza Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
Table 10. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Avian Influenza Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Avian Influenza Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Avian Influenza Vaccines Sales by Manufacturers (2016-2021) (M Doses)
Table 14. Global Avian Influenza Vaccines Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Avian Influenza Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 16. Avian Influenza Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Avian Influenza Vaccines Revenue Share by Manufacturers (2016-2021)
Table 18. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avian Influenza Vaccines as of 2020)
Table 20. Key Manufacturers Avian Influenza Vaccines Price (2016-2021) (USD/K Doses)
Table 21. Avian Influenza Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Avian Influenza Vaccines Product Type
Table 23. Date of International Manufacturers Enter into Avian Influenza Vaccines Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Avian Influenza Vaccines Sales by Type (2016-2021) (M Doses)
Table 26. Global Avian Influenza Vaccines Sales Share by Type (2016-2021)
Table 27. Global Avian Influenza Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Avian Influenza Vaccines Revenue Share by Type (2016-2021)
Table 29. Avian Influenza Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/K Doses)
Table 30. Global Avian Influenza Vaccines Sales Forecast by Type (2022-2027) & (M Doses)
Table 31. Global Avian Influenza Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Avian Influenza Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Avian Influenza Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Avian Influenza Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/K Doses)
Table 35. Global Avian Influenza Vaccines Sales by Application (2016-2021) (M Doses)
Table 36. Global Avian Influenza Vaccines Sales Share by Application (2016-2021)
Table 37. Global Avian Influenza Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Avian Influenza Vaccines Revenue Share by Application (2016-2021)
Table 39. Avian Influenza Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/K Doses)
Table 40. Global Avian Influenza Vaccines Sales Forecast by Application (2022-2027) & (M Doses)
Table 41. Global Avian Influenza Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Avian Influenza Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Avian Influenza Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Avian Influenza Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/K Doses)
Table 45. Japan Avian Influenza Vaccines Sales (M Doses) of Key Companies (2016-2021)
Table 46. Japan Avian Influenza Vaccines Sales Share by Company (2016-2021)
Table 47. Japan Avian Influenza Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Avian Influenza Vaccines Revenue Share by Company (2016-2021)
Table 49. Japan Avian Influenza Vaccines Sales (M Doses) by Type (2016-2021)
Table 50. Japan Avian Influenza Vaccines Sales Share by Type (2016-2021)
Table 51. Japan Avian Influenza Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Avian Influenza Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 53. Japan Avian Influenza Vaccines Sales (M Doses) by Type (2022-2027)
Table 54. Japan Avian Influenza Vaccines Sales Share by Type (2022-2027)
Table 55. Japan Avian Influenza Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Avian Influenza Vaccines Revenue Share by Type (2022-2027)
Table 57. Japan Avian Influenza Vaccines Price (USD/K Doses) by Type (2022-2027)
Table 58. Japan Avian Influenza Vaccines Sales (M Doses) by Application (2016-2021)
Table 59. Japan Avian Influenza Vaccines Sales Share by Application (2016-2021)
Table 60. Japan Avian Influenza Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Avian Influenza Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 62. Japan Avian Influenza Vaccines Sales (M Doses) by Application (2022-2027)
Table 63. Japan Avian Influenza Vaccines Sales Share by Application (2022-2027)
Table 64. Japan Avian Influenza Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Avian Influenza Vaccines Revenue Share by Application (2022-2027)
Table 66. Japan Avian Influenza Vaccines Price (USD/K Doses) by Application (2022-2027)
Table 67. North America Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 68. North America Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 69. North America Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Avian Influenza Vaccines Sales by Region (2016-2021) & (M Doses)
Table 72. Asia Pacific Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Avian Influenza Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Avian Influenza Vaccines Revenue Market Share by Region (2016-2021)
Table 75. Europe Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 76. Europe Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 77. Europe Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 79. Latin America Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 80. Latin America Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 84. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 87. Merial Corporation Information
Table 88. Merial Description and Business Overview
Table 89. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 90. Merial Avian Influenza Vaccines Product
Table 91. Merial Recent Development
Table 92. QYH Biotech Corporation Information
Table 93. QYH Biotech Description and Business Overview
Table 94. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 95. QYH Biotech Product
Table 96. QYH Biotech Recent Development
Table 97. DHN Corporation Information
Table 98. DHN Description and Business Overview
Table 99. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 100. DHN Product
Table 101. DHN Recent Development
Table 102. HVRI Corporation Information
Table 103. HVRI Description and Business Overview
Table 104. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 105. HVRI Product
Table 106. HVRI Recent Development
Table 107. CEVA Corporation Information
Table 108. CEVA Description and Business Overview
Table 109. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 110. CEVA Product
Table 111. CEVA Recent Development
Table 112. Elanco (Lohmann ) Corporation Information
Table 113. Elanco (Lohmann ) Description and Business Overview
Table 114. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 115. Elanco (Lohmann ) Product
Table 116. Elanco (Lohmann ) Recent Development
Table 117. Yebio Corporation Information
Table 118. Yebio Description and Business Overview
Table 119. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 120. Yebio Product
Table 121. Yebio Recent Development
Table 122. Zoetis Corporation Information
Table 123. Zoetis Description and Business Overview
Table 124. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 125. Zoetis Product
Table 126. Zoetis Recent Development
Table 127. FATRO Corporation Information
Table 128. FATRO Description and Business Overview
Table 129. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 130. FATRO Product
Table 131. FATRO Recent Development
Table 132. Kyoto Biken Corporation Information
Table 133. Kyoto Biken Description and Business Overview
Table 134. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 135. Kyoto Biken Product
Table 136. Kyoto Biken Recent Development
Table 137. CAVAC Corporation Information
Table 138. CAVAC Description and Business Overview
Table 139. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 140. CAVAC Product
Table 141. CAVAC Recent Development
Table 142. Ringpu Biology Corporation Information
Table 143. Ringpu Biology Description and Business Overview
Table 144. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 145. Ringpu Biology Product
Table 146. Ringpu Biology Recent Development
Table 147. Vaksindo Corporation Information
Table 148. Vaksindo Description and Business Overview
Table 149. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 150. Vaksindo Product
Table 151. Vaksindo Recent Development
Table 152. ChengDu Tecbond Corporation Information
Table 153. ChengDu Tecbond Description and Business Overview
Table 154. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 155. ChengDu Tecbond Product
Table 156. ChengDu Tecbond Recent Development
Table 157. Sindh Poultry Vaccine Centre Corporation Information
Table 158. Sindh Poultry Vaccine Centre Description and Business Overview
Table 159. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 160. Sindh Poultry Vaccine Centre Product
Table 161. Sindh Poultry Vaccine Centre Recent Development
Table 162. Merck Animal Health Corporation Information
Table 163. Merck Animal Health Description and Business Overview
Table 164. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 165. Merck Animal Health Product
Table 166. Merck Animal Health Recent Development
Table 167. Medion Corporation Information
Table 168. Medion Description and Business Overview
Table 169. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 170. Medion Product
Table 171. Medion Recent Development
Table 172. Avimex Animal Health Corporation Information
Table 173. Avimex Animal Health Description and Business Overview
Table 174. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 175. Avimex Animal Health Product
Table 176. Avimex Animal Health Recent Development
Table 177. JOVAC Corporation Information
Table 178. JOVAC Description and Business Overview
Table 179. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 180. JOVAC Product
Table 181. JOVAC Recent Development
Table 182. Bio-Labs Corporation Information
Table 183. Bio-Labs Description and Business Overview
Table 184. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 185. Bio-Labs Product
Table 186. Bio-Labs Recent Development
Table 187. Avian Influenza Vaccines Market Trends
Table 188. Avian Influenza Vaccines Market Drivers
Table 189. Avian Influenza Vaccines Market Challenges
Table 190. Avian Influenza Vaccines Market Restraints
Table 191. Avian Influenza Vaccines Customers List
Table 192. Avian Influenza Vaccines Distributors List
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Global Avian Influenza Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. H5+H7 Avian Influenza Vaccines Product Picture
Figure 4. H9 Avian Influenza Vaccines Product Picture
Figure 5. Global Avian Influenza Vaccines Sales Market Share by Application in 2020 & 2027
Figure 6. Chicken Avian Influenza Vaccines
Figure 7. Duck & Goose Avian Influenza Vaccines
Figure 8. Other
Figure 9. Avian Influenza Vaccines Report Years Considered
Figure 10. Global Avian Influenza Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Avian Influenza Vaccines Market Size 2016-2027 (US$ Million)
Figure 12. Global Avian Influenza Vaccines Sales 2016-2027 (M Doses)
Figure 13. Global Avian Influenza Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Figure 15. Global Avian Influenza Vaccines Sales Market Share by Region in 2020
Figure 16. Global Avian Influenza Vaccines Revenue Market Share by Region (2016-2021)
Figure 17. Global Avian Influenza Vaccines Revenue Market Share by Region in 2020
Figure 18. Global Avian Influenza Vaccines Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Avian Influenza Vacci
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs